{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenosquamous+Cell+Carcinoma+of+the+Cervix", "query": { "condition": "Adenosquamous Cell Carcinoma of the Cervix" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 67, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenosquamous+Cell+Carcinoma+of+the+Cervix&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T03:16:05.409Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01266460", "title": "Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Adenocarcinoma", "Cervical Adenosquamous Carcinoma", "Cervical Squamous Cell Carcinoma, Not Otherwise Specified", "Recurrent Cervical Carcinoma" ], "interventions": [ { "name": "Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001", "type": "BIOLOGICAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 54, "start_date": "2011-05-23", "completion_date": "2018-10-02", "has_results": true, "last_update_posted_date": "2020-09-11", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01266460" }, { "nct_id": "NCT00070317", "title": "Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Adenocarcinoma", "Cervical Adenosquamous Carcinoma", "Cervical Squamous Cell Carcinoma", "Stage I Cervical Cancer" ], "interventions": [ { "name": "Isosulfan Blue", "type": "DRUG" }, { "name": "Lymph Node Mapping", "type": "PROCEDURE" }, { "name": "Lymphangiography", "type": "PROCEDURE" }, { "name": "Methylene Blue", "type": "DRUG" }, { "name": "Radionuclide Imaging", "type": "PROCEDURE" }, { "name": "Sentinel Lymph Node Biopsy", "type": "PROCEDURE" }, { "name": "Technetium Tc-99m Sulfur Colloid", "type": "RADIATION" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 102, "start_date": "2004-06", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2017-11-06", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00070317" }, { "nct_id": "NCT00006224", "title": "Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": null, "start_date": "2000-09", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-04-11", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Los Angeles, California • Los Gatos, California + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Gatos", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006224" }, { "nct_id": "NCT00004936", "title": "MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "iodinated contrast dye", "type": "DRUG" }, { "name": "computed tomography", "type": "PROCEDURE" }, { "name": "magnetic resonance imaging", "type": "PROCEDURE" }, { "name": "gadopentetate dimeglumine", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "American College of Radiology Imaging Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": null, "start_date": "2000-04", "completion_date": "2002-10", "has_results": false, "last_update_posted_date": "2013-01-28", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 2, "location_summary": "Morristown, New Jersey • New York, New York", "locations": [ { "city": "Morristown", "state": "New Jersey" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004936" }, { "nct_id": "NCT04574635", "title": "Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Adenosquamous Carcinoma", "Cervical Squamous Cell Carcinoma, Not Otherwise Specified", "Infiltrating Cervical Carcinoma", "Metastatic Cervical Carcinoma", "Recurrent Cervical Carcinoma", "Stage I Cervical Cancer FIGO 2018", "Stage IA Cervical Cancer FIGO 2018", "Stage IA1 Cervical Cancer FIGO 2018", "Stage IA2 Cervical Cancer FIGO 2018", "Stage IB Cervical Cancer FIGO 2018", "Stage IB1 Cervical Cancer AJCC v8", "Stage IB2 Cervical Cancer FIGO 2018", "Stage IB3 Cervical Cancer FIGO 2018", "Stage II Cervical Cancer FIGO 2018", "Stage IIA Cervical Cancer FIGO 2018", "Stage IIA1 Cervical Cancer FIGO 2018", "Stage IIA2 Cervical Cancer FIGO 2018", "Stage IIB Cervical Cancer FIGO 2018", "Stage III Cervical Cancer FIGO 2018", "Stage IIIA Cervical Cancer FIGO 2018", "Stage IIIB Cervical Cancer FIGO 2018", "Stage IIIC Cervical Cancer FIGO 2018", "Stage IIIC1 Cervical Cancer FIGO 2018", "Stage IIIC2 Cervical Cancer FIGO 2018", "Stage IV Cervical Cancer FIGO 2018", "Stage IVA Cervical Cancer FIGO 2018", "Stage IVB Cervical Cancer FIGO 2018" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 18, "start_date": "2020-11-17", "completion_date": "2027-11-30", "has_results": false, "last_update_posted_date": "2025-10-27", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Rochester, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04574635" }, { "nct_id": "NCT00023660", "title": "Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "celecoxib", "type": "DRUG" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "FEMALE", "summary": "18 Years to 85 Years · Female only" }, "enrollment_count": 84, "start_date": "2001-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-19", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 36, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Burlingame, California + 30 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Burlingame", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00023660" }, { "nct_id": "NCT00331760", "title": "Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Cancer", "Endometrial Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "intensity-modulated radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 106, "start_date": "2006-03", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-02-26", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 151, "location_summary": "Auburn, California • Cameron Park, California • Carmichael, California + 103 more", "locations": [ { "city": "Auburn", "state": "California" }, { "city": "Cameron Park", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "Castro Valley", "state": "California" }, { "city": "Castro Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00331760" }, { "nct_id": "NCT00003379", "title": "Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 40, "start_date": "1999-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-05-27", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Newark, Delaware • Chicago, Illinois + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Newark", "state": "Delaware" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Decatur", "state": "Illinois" }, { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003379" }, { "nct_id": "NCT00068549", "title": "Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cervical Adenocarcinoma", "Cervical Adenosquamous Carcinoma", "Cervical Small Cell Carcinoma", "Cervical Squamous Cell Carcinoma", "Stage IB Cervical Cancer", "Stage IIA Cervical Cancer", "Stage IIB Cervical Cancer", "Stage III Cervical Cancer", "Stage IVA Cervical Cancer" ], "interventions": [ { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Internal Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 13, "start_date": "2003-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-12-25", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00068549" }, { "nct_id": "NCT00012012", "title": "Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cervical Cancer", "Radiation Toxicity" ], "interventions": [ { "name": "Amifostine trihydrate", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Intracavitary brachytherapy", "type": "RADIATION" }, { "name": "External beam radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 45, "start_date": "2001-08", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2015-01-07", "last_synced_at": "2026-07-23T03:16:05.409Z", "location_count": 17, "location_summary": "Jacksonville, Florida • Jacksonville Beach, Florida • Jascksonville, Florida + 11 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville Beach", "state": "Florida" }, { "city": "Jascksonville", "state": "Florida" }, { "city": "Orange Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00012012" } ] }